FZD1 and breast carcinoma: FZD1/2/7 form a subgroup with nearly identical CRDs within the FZD family and FZD7 has been previously shown to be associated with triple-negative breast cancer and targeting FZD7 may reduce growth of breast cancer cells [22–25].